Talbot Woods Lodge

Inspectors found enough staff to support people in the way they preferred. Relatives also described staffing levels positively.

“Enough staff were on duty to provide the care and support people needed in the way they preferred.” from the report

People appeared relaxed with staff, and staff understood their wishes and support needs.

“People were relaxed and at ease with staff.” from the report

With staff support, people routinely used medical, dental and primary healthcare services. The home worked with other organisations to support people's health.

“With support from staff, people routinely accessed medical, dental, and primary healthcare services as they needed.” from the report

The home was clean, comfortable and maintained well. People could use their bedrooms, communal areas and enclosed garden freely.

“The premises were clean, comfortable and well maintained.” from the report

There were no best-interests decisions for physical restraint. A decision about covert medicines did not cover all the medicines involved, creating a risk that care could be unlawful.

“Best interests decisions had not been completed in relation to the use of physical restraint” from the report

Audits and reviews had not identified the problems with consent, DoLS, notifications, medicines and restraint planning. The provider was in breach of the good governance regulation.

“Although there were regular audits and reviews of various aspects of the service, these had not identified the breaches in regulation and areas for improvement that we found.” from the report

Some legally notifiable incidents were not reported to CQC promptly or using the required format. This included safeguarding allegations, a police investigation and DoLS-related matters.

“Notifiable incidents had not always been notified to CQC without delay, in the specified format.” from the report

Staff understood when some as-required medicines were needed, but written instructions were not available for every as-required medicine.

“However, such written guidance should be available for all PRN medicines.” from the report